Finance

Lists
19T:FRA
Idorsia Ltd
€5.44
+2.64%
(+0.14) 1D
Sep 8, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 19T...
Open
€5.44
High
€5.44
Low
€5.44
Mkt. cap
1.38B
Avg. vol.
133.00
Volume
0.00
52-wk high
€8.09
52-wk low
€3.06
No. of employees
456
Open
€5.44
High
€5.44
Low
€5.44
Mkt. cap
1.38B
Avg. vol.
133.00
Volume
0.00
52-wk high
€8.09
52-wk low
€3.06
No. of employees
456
Profile
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
About Idorsia Ltd
CEO-
Employees456
Founded2017
Headquarters-
SectorBiotechnology
Websiteidorsia.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
41.49M
47.97M
57.39M
52.86M
Cost of goods sold
30.25M
36.94M
31.81M
37.73M
Cost of revenue
30.25M
36.94M
31.81M
37.73M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.47M
63.45M
51.46M
50.16M
Operating expense
51.43M
62.84M
52.11M
51.53M
Total operating expenses
81.67M
99.78M
83.92M
89.26M
Operating income
-40.19M
-51.81M
-26.53M
-36.40M
Other non operating income
14.54M
-31.45M
-451.00K
191.00K
EBT including unusual items
-85.50M
-75.91M
-46.18M
-105.97M
EBT excluding unusual items
-50.34M
-65.08M
-46.32M
-58.91M
Income tax expense
180.00K
1.85M
-486.00K
1.08M
Effective tax rate
-0.21%
-2.44%
1.05%
-1.02%
Other operating expenses
-4.55M
-2.19M
-653.00K
-53.00K
Net income
-85.68M
-77.76M
-45.70M
-107.05M
Net profit margin
-206.52%
-162.09%
-79.62%
-202.52%
Earnings per share
-
-
-
-
Interest and investment income
-
9.48M
-
50.00K
Interest expense
-15.39M
-
-19.35M
-21.65M
Net interest expenses
-15.39M
9.48M
-19.35M
-21.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.04M
-47.78M
-22.77M
-32.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps